Skyrizi 180 MG/1.2 ML on-body 1.2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG2FV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,401
Award facts
- Contract value 100% obligated
- $37,401.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37.4K firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 180 mg/1.2 ml on-body injector units, with performance in Conshohocken, Pennsylvania and completion targeted for January 7, 2026. This non-set-aside award was made on December 15, 2025, and represents a competitive procurement for pharmaceutical products supporting federal medical supply needs. SKYRIZI is a biologic medication used to treat inflammatory conditions, and this delivery order fulfills medical procurement requirements within the Defense Logistics Agency's pharmaceutical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas to support military and veteran healthcare systems. The parent indefinite delivery contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply diverse medical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FG2FV?
SPE2DR26FG2FV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FG2FV worth?
The government has obligated $37,401 on SPE2DR26FG2FV.
Is contract SPE2DR26FG2FV an order under another contract?
Yes. SPE2DR26FG2FV is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2FV competed?
The extent of competition for SPE2DR26FG2FV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award